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Abstract. ERGIC-53 is a lectin-type membrane pro- 
tein that continuously recycles between the ER, ER- 
Golgi intermediate compartment (ERGIC) and the cis- 
Golgi. To identify the targeting signals that mediate this 
recycling, N-glycosylated and myc-tagged variants of 
ERGIC-53 were constructed. By monitoring endogly- 
cosidase H resistance, we measured the loss from the 
ER-ERGIC-cis-Golgi cycle of ERGIC-53. A domain 
exchange approach with the plasma membrane r - 
porter protein CD4 showed that the transmembrane 
and the lumenal domains are not sufficient, while the 
cytoplasmic domain of ERGIC-53 is required and suffi- 
cient for pre-medial-Golgi localization. However, the 
ERGIC-53 cytoplasmic domain on CD4 lead to in- 
creased ER-staining by immunofluorescence micros- 
copy indicating that this domain alone cannot provide 
for unbiased recycling through the ER-ERGIC-cis- 
Golgi compartments. Complete progress through the 
ER-ERGIC-cis-Golgi recycling pathway requires the 
cytoplasmic domain acting together with the lumenal 
domain of ERGIC-53. Dissection of the cytoplasmic 
domain revealed a COOH-terminal di-lysine ER- 
retrieval signal, KKFF, and an RSQQE targeting deter- 
minant adjacent to the transmembrane domain. Sur- 
prisingly, the two COOH-terminal phenylalanines 
influence the targeting. They reduce the ER-retrieval 
capacity of the di-lysine signal and modulate the 
RSQQE determinant. 
OCALIZATION of resident membrane proteins in the 
secretory pathway is achieved by two targeting 
mechanisms: protein retention and retrieval of trans- 
ported proteins from a later compartment (Pelham and 
Munro, 1993; Nilsson and Warren, 1994). 
Protein retention describes a process by which proteins 
are excluded from incorporation i to transport vesicles. 
Such a process has been reported for Golgi membrane 
proteins: the M-protein of avian coronavirus forms large 
homooligomers in the cis-Golgi via its transmembrane do-
mains leading to large aggregates unable to enter the 
coated bud (Swift and Machamer et al., 1991; Machamer 
et aL, 1993; Weisz et al., 1993). A similar type of aggregate 
was proposed to form between glycosylation enzymes of 
the Golgi apparatus which are known to be retained by 
their transmembrane domains (Nilsson et al., 1991; Munro, 
1991; Aoki et al., 1992; Burke et al., 1992; Colley et al., 
1992; Russo et al., 1992; Tang et al., 1992; Teasdale t al., 
1992; Wong et al., 1992). Since the concentration f Golgi 
glycosylation enzymes cannot reach that of a viral protein, 
Golgi enzymes are believed to form large heterooligo- 
meric complexes by kin recognition (Nilsson et al., 1993). 
Although a direct heterooligomeric interaction among 
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Golgi proteins remains to be shown, the kin recognition 
hypothesis supported by the observation that artificial 
retention i  the ER of the medial-Golgi enzyme GlcNAc- 
transferase results in the retention of another medial- 
Golgi enzyme, mannosidase II (Nilsson et al., 1994). 
Localization by protein retrieval is a fundamentally dif- 
ferent process. Here, membrane proteins enter budding 
vesicles and are transported to the next compartment, 
where they are recognized by a receptor and sorted into 
vesicles destined for recycling to the compartment of ori- 
gin (Pelham and Munro, 1993). Such a process was de- 
scribed for type I membrane proteins of the ER that con- 
tain a COOH-terminal di-lysine ER-retrieval signal, KKXX 
or KXKXX, in their cytoplasmic domain (Jackson et al., 
1990). In mammalian and in yeast cells these proteins can 
leave the ER and recycle from a post-ER compartment 
(Jackson et al., 1993; Gaynor et al., 1994; Townsley et al., 
1994). Di-lysine signals were shown to bind coatomer in 
vitro (Cosson and Letourneur, 1994) and mutations in 
yeast coatomer subunits effect he intracellular retention 
of di-lysine proteins in vivo (Letourneur et al., 1994). 
These findings support a coatomer-mediated r trieval 
mechanism for di-lysine ER proteins. 
The mannose-specific lectin ERGIC-53 (Schindler et al., 
1993; Arar et al., 1995) is predominantly associated with the 
ER-Golgi intermediate compartment (ERGIC) 1 (Schwei- 
1. Abbreviations used in this paper: ERGIC, ER-Golgi intermediate com- 
partment; endo H, endoglycosidase H. 
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zer et al., 1988, 1990, 1991). Due to continuous recycling, 
ERGIC-53 and its rat homologue p58 (Saraste and Svens- 
son, 1991) are also present at lower concentrations in the 
rough ER and in the first fenestrated cis-cisternae of the 
stacked Golgi (Foguet, M., and H.-P. Hauri, unpublished 
observation; Schweizer et al., 1988; Chavrier et al., 1990). 
ERGIC-53 is a 53-kD nonglycosylated type I transmem- 
brane protein that assembles into equal amounts of disul- 
fide-linked homodimers and homohexamers (Schweizer et 
al., 1988; Schindler et al., 1993). It has a large lumenal do- 
main exhibiting homology to leguminous lectins and mam- 
malian galectins, a single transmembrane s gment, and a 
short 12-amino acid long cytoplasmic domain (Schindler 
et al., 1993; Fiedler and Simons, 1994; Arar et al., 1995). 
The cytoplasmic domain contains a COOH-terminal tet- 
rapeptide, KKFF, matching the consensus for a di-lysine 
ER-retrieval signal. 
We show that targeting of ERGIC-53 cannot be explained 
by a simple retrieval mechanism, since proper localization 
required the lumenal and the cytoplasmic domains. The 
cytoplasmic domain possesses three determinants all of 
which are required for correct argeting within the ER- 
ERGIC-cis-Golgi recycling pathway: a functional di-lysine 
ER-retrieval signal, KKFF, a targeting determinant adja- 
cent to the membrane, RSQQE, and two COOH-terminal 
phenylalanines that reduce the retrieval efficiency of the 
di-lysine signal and modulate the RSQQE targeting deter- 
minant. Thus the ER-retrieval signal, although critical for 
retaining ERGIC-53 in the ER-ERGIC-cis-Golgi recy- 
cling pathway, is not sufficient for the correct distribution 
throughout these compartments. Targeting of ERGIC-53 
depends on a complex interplay of multiple determinants. 
Materials and Methods 
Materials 
Monoclonal antibodies used included HP2/6.1 (IgG2A)(Carrera et al., 
1987) and 6D10 (IgG1) against human CD4. In addition the following 
mAb hybridoma supernatants (N10-fold concentrated by ammonium sul- 
fate precipitation) were used: 9E10.2 (IgG1)(Evan et al., 1985) against a
c-myc epitope (ATCC CRL 1729; American Type Culture Collection, 
Rockville, MD), G1/93 (IgG1) against ERGIC-53 (Schweizer et al., 1988), 
G1/221 (IgG1) against human transferrin receptor, G1/296 (IgG12A) 
against p63 (Schweizer et al., 1993), G1/133 (IgG1) against giantin (Lin- 
stedt and Hauri, 1993). [35S]methionine was isolated from Escherichia coli 
grown under sulfur-limited conditions in the presence of [35S]sulfate (New 
England Nuclear, Boston, MA). Protease inhibitors (used at the following 
final concentration 1 ~g/ml pepstatin, 1 p~g/ml aprotitin, 0.5 ~Lg/ml leupep- 
tin, 1 ixg/rrd benzamidin, 1 i-~g/ml antipain, and 0.2 mM phenylmethylsulfonyl 
fluoride), cycloheximide and nocodazole were from Sigma Chem. Co. (St. 
Louis, MO). 
Recombinant DNAs 
The c-myc epitope tagged and N-glycosylated form of ERGIC-53 desig- 
nated GM is shown in Fig. 1. The DNA sequence coding for the c-myc 
epitope EQKLISEEDL was introduced after the signal sequence at the 
amino acid position 31 of ERGIC-53 by PCR-based splicing (Horton et 
al., 1989). The PCR amplified DNA was cloned back to the ERGIC-53 
cDNA (Schindler et al., 1993) via the Sacll site at position 116 leading to 
P53cmyc. In a second reaction aspartic acid at position 61 of wild-type 
ERGIC-53 was mutated to asparagine by PCR mutagenesis (Ho et al., 
1989) leading to a NGT N-glycosylation consensus site. The PCR-ampli- 
fled DNA was ligated to the ERGIC-53 cDNA via the BglI restriction site 
at position 269. This construct was termed P53G1. The relegated DNA 
was treated with Klenow and cloned into the EcoRV site of Bluescript SK 
vector (Stratagene, La Jolla, CA). Both constructs were cloned into pECE 
to test for expression i  COS cells. To create the final GM construct the 
two mutations were combined by ligating the cmyc tagged 5'-end of 
P53cmyc via the SacI site at position 116 to P53G1. For expression i COS 
cells GM was cloned as a SalI/XbaI fragment into the pECE expression 
vector (Ellis et al., 1986). All mutations were confirmed by DNA-sequenc- 
ing (Sequenase 2.0; US Biochemical Co., Cleveland, OH). 
For further mutagenesis, GM was cloned as a ClaI/XbaI fragment into 
AccI/XbaI cut pECE. The resulting plasmid was designated pECE*. This 
cloning step eliminated the single AccI site in pECE so that the Accl site 
in GM at position 1429 became unique. All further constructs which con- 
tained the ERGIC-53 lumenal domain were generated by PCR using 
3'-primers with a terminal XbaI restriction site. This allowed direct clon- 
ing of the PCR-amplified sequences as AccI/XbaI fragments into pECE* 
that were then confirmed by sequencing. 
Chimeric proteins between ERGIC-53 and human CD4 (Maddon et 
al., 1985) were constructed by PCR based splicing by overlap extension 
(Horton et al., 1989). L4T53C53 was entirely generated by PCR introduc- 
ing a EcoRI site at the 5'- and a BamHI site at the 3'-end of the coding se- 
quence. This construct was fully sequenced. The PCR amplified sequences 
of all further constructs containing the CD4 lumenal domain were ligated 
back to the IMT53C53 DNA via either the TaqI site at position 1129 of the 
human CD4 cDNA or the AvaI site at position 1197. These DNAs were 
treated with Klenow, ligated into the EcoRV site of Bluescript SK, and 
confirmed by sequencing. For expression i  mammalian cells these con- 
structs were cloned into pCB6 (Brewer and Roth, 1991); CD4, I.AT53C53 
as EcoR/BamHI fragments, L4T4C53 as an EcoRI and LAT4C53 
K(-4)stop as a EcoRI/XbaI fragment. 
Cell Culture and Transfection 
COS-1 cells were grown in DME supplemented with 10% FCS, 100 IU/ml 
penicillin, 100 p.g/ml streptomycin, and 1 ixg/ml fungizone. COS cells were 
transfected using the DEAE-Dextran method (Cullen, 1987). 2 p.g DNA 
per 35-mm dish was used. 
Immunofluorescence 
All immunofluorescence experiments were carried out in eight-well multi- 
chamber glass slides (Miles Labs, Naperville, IL). 42-48 h after transfec- 
tion the slides were fixed with paraformaldehyde and processed for indi- 
rect immunofluorescence. Saponine-permeabilized c lls were stained as 
described (Schweizer et al., 1988). Primary antibody dilutions were as fol- 
lows: anti-ERGIC-53 (G1/93) 1:50 for endogenous ERGIC-53; 1:2,000 for 
overexpressed ERGIC-53; anti-c-myc epitope (9E10.2) 1:50; anti human 
CD4:HP2/6.1 1:150 (10x concentrated culture supernatant), HP2/6.1 as- 
cites 1:4000, 6D10 1:50; anti-giantin (G1/133) 1:50; anti-p63 (G1/296) 1:50; 
anti-transferrin receptor (G1/221) 1:50. 
For surface staining of ERGIC-53 and mutants the cells were cooled to 
4°C for 20 min followed by an incubation with G1/93 or 9E10.2 at a 1:10 
dilution in 250 txl culture medium for 30 rain. After six washes with culture 
medium the cells were fixed with 3% paraformaldehyde, pH 8.3, for 30 
min. Thereafter the cells were rewarmed to room temperature, fixed for 
another 30 min, washed twice with PBS and twice with PBS containing 20 
mM glycine, and then permeabilized for 20 min with PBS-glycine contain- 
ing 0.1% saponine. The cells were then subjected to indirect immunofluo- 
rescence microscopy as described below. For differential staining of the 
cell surface and intraceUular structures of CD4 and CD4/ERGIC-53 chi- 
meric proteins the following double-immunofluorescence protocol was 
applied. The cells were cooled to 4°C for 20 min followed by an incubation 
with mAb 6D10 at a dilution of 1:10 in culture medium for 30 min. After 
six washes with culture medium the cells were reincubated with IgGl-spe- 
cific FITC-labeled affinity-purified goat anti-mouse secondary antibody 
(Cappel, West Chester, PA) for 30 rain, washed again six times with cul- 
ture medium, and fixed with 3% paraformaldehyde, pH 8.3, for 30 min. 
Thereafter the cells were rewarmed to room temperature, fixed for an- 
other 30 rain, washed twice with PBS and twice with PBS containing 20 
mM glycine, and then permeabilized for 20 min with PBS-glycine contain- 
ing 0.1% saponine. The cells were then incubated with HP2/6.1 at a 1:150 
dilution in PBS-saponine for 30 min, washed four times with PBS-sapo- 
nine, and incubated with rhodamine (TRITC)-labeled IgG2a-specific af- 
finity-purified goat anti-mouse secondary antibody (Cappel) for 30 min. 
After four final washes with PBS-saponine the cells were mounted in 90% 
glycerol, 10% PBS, and 0.1 mg/ml phenylenediamine. The cells were ana- 
lyzed by a Reichert Polyvar immunofluorescence microscope. 
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Pulse-Chase Experiments and lmmunoprecipitation 
42 h after transfection the cells were washed once with PBS, incubated in 
labeling medium (PBS, 20% dialyzed FCS, 100 IU/ml penicillin, 100 g,g/ml 
streptomycin, 1% nonessential mino acids) for 15 min at 37°C and pulsed 
for 5 rain at 370C with 20 txCi [35S]methionine in 200 Ixl labeling medium 
per 35-mm dish. The cells were washed once with cold DMEM containing 
10 mM methionine and then chased in DMEM containing 10 mM me- 
thionine at 37°C. The dishes were transferred to ice and all the subsequent 
steps were carried out on ice. The cells were washed twice with PBS, once 
with 100 mM sodium phosphate, 1% bovine serum albumin, pH 8, scraped 
off with a rubber policeman in 1 ml solubilization buffer (100 mM sodium 
phosphate, 1% Triton X-100, pH 8, and protease inhibitors), and passed 
five times through a 25-gauge needle. After incubation for 60 min the ly- 
sate was centrifuged at 100,000 g for 60 min, the resulting supernatant was 
incubated with either 2 ixl G1/93 ascites, 20 I~19E10.2, or 20 Ixl HP2/6.1 for 
60 min followed by an incubation with 2 t~1 rabbit anti-mouse IgG (Cap- 
pel) for 30 min. Immunocomplexes were isolated by adding 10 Ixl protein 
A-Sepharose (Pharmacia, Uppsala, Sweden), rotated over night at 4°C, 
washed four times with solubilization buffer, once with 100 mM sodium 
phosphate, pH 8, and once with 10 mM sodium phosphate, pH 8. Proteins 
were eluted from the protein A beads by boiling in electrophoresis ample 
buffer. For nonreduced samples 4-10%, for reduced samples 7-10% 
SDS-polyacrylamide gradient slab gels (Laemmli, 1970) were run, salicy- 
lated, and visualized by fluorography using Kodak X-omat AR or Fuji RX 
films. 
Endoglycosidase H Digestion 
Immunoprecipitates were released from the protein A-Sepharose beads 
by boiling for 3 min in 30 Ixl 200 mM Na-citrate, pH 5.5, 2% SDS in the 
presence of protease inhibitors, frozen at -20°C for 30 rain, and boiled 
again for 3 min. Then the samples were diluted with an equal volume of 
distilled water containing protease inhibitors and incubated with 4 mU en- 
doglycosidase H (endo H) for 22 h at 37°C. 
Results 
Characterization of the Epitope-tagged 
and N-glycosylated ER GIC-53 
ERGIC-53 has no posttranslational modifications that 
would allow to monitor changes in intracellular localiza- 
tion (Schweizer et at., 1988). To study loss of pre-medial- 
Golgi targeting directly we constructed a N-glycosylated, 
epitope-tagged variant of ERGIC-53 (Fig. 1, GM). We used 
this construct o measure ER to medial-Golgi transport 
rates in pulse-chase experiments based on the acquisition 
of endo H resistance of its glycan moiety. Acquisition of 
endo H resistance is a medial-Golgi event, and therefore 
reflects the fraction of ERGIC-53 that has escaped the 
ER-ERGIC-cis-Golgi cycle. 
To determine if ERGIC-53 (GM) behaves identical to 
overexpressed wild-type ERGIC-53, COS-1 cells were tran- 
siently transfected with the corresponding DNAs and ana- 
lyzed by pulse-labeling with [35S]methionine followed by 
immunoprecipitation, r by indirect immunofluorescence 
microscopy. The introduced c-myc epitope tag was recog- 
nized by the epitope-specific mAb 9E10 (Evan et al., 1985) 
both in indirect immunofluorescence experiments (Fig. 2, 
e and f) and immunoprecipitation (Fig. 3). In pulse-chase 
experiments GM and overexpressed wild-type ERGIC-53 
displayed virtually identical expression levels and oligo- 
merization (Fig. 3), and the localization revealed by immu- 
nofluorescence microscopy indicates that the modifica- 
tions did not alter the intracellular distribution compared 
to overexpressed wild type (Fig. 2). However, both over- 
expressed proteins howed a staining of the cell periphery 
Figure 1. Schematic representation of ERGIC-53 domain- 
exchanged constructs. ERGIC-53 constructs contain a N-glycosy- 
lation site introduced at amino acid position 61 of ERGIC-53, 
(CHO), and a c-myc epitope tag introduced after the signal se- 
quence cleavage site, (MYC). The amino acid sequence of the cy- 
toplasmic domain of the ERGIC-53 constructs is given in the sin- 
gle letter code. L, lumenal domain; T, trans-membrane domain; 
C, cytoplasmic domain; 4, CD4; 53, ERGIC-53. The transmem- 
brane domain T53 consists of the hydrophobic residues 481-498 
of ERGIC-53 (Schindler tal., 1993) and T4 comprises the hy- 
drophobic residues 375-395 of human CD4 (Maddon et al., 1985). 
typical for ER, and led to a comparable fraction of trans- 
fected ceils exhibiting surface staining (compare Fig. 2, c 
and d with e and f). Cells expressing identical levels of 
ERGIC-53 or GM bound equal amounts of radio-iodi- 
nated mAb to ERGIC-53 suggesting identical loss of both 
proteins from the ER-ERGIC-cis-Golgi recycling path- 
way (data not shown). After immunoprecipitation of GM 
with mAb 9El0 against he c-myc epitope, digestion with 
endo H confirmed that the introduced N-glycosylation 
consensus ite was glycosylated and that the oligomer- 
ization state of GM was identical to that of ERGIC-53 
(Fig. 3). The kinetics of oligomerization of endogenous 
ERGIC-53 in nontransfected cells and that of overex- 
pressed GM or ERGIC-53 in transfected cells was identi- 
cal (not shown), indicating that the overall folding of GM 
is indistinguishable from ERGIC-53, and overexpressed 
ERGIC-53 and GM showed the same half-life in pulse- 
chase experiments (not shown). In Fig. 3 hardly any en- 
dogenous ERGIC-53 is coprecipitated with GM dem- 
onstrating that disulfide-linked heterooligomers between 
GM and endogenous ERGIC-53 should not influence the 
interpretation of a mutational analysis. We conclude that 
overexpression f the GM construct in COS-1 cells fulfills 
the criteria required for a mutational analysis of the tar- 
geting determinant(s) of ERGIC-53. 
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Figure 2. Immunofluorescence 
localization of overexpressed 
ERGIC-53 and GM. COS cells 
were mock-transfected (a and 
b), or transfected with ER- 
GIC-53 cDNA (c and d) or 
GM cDNA (e and]). 44 h after 
transfection the cells were 
stained before fixation and 
permeabilization at 4°C (b, d, 
and f), or after fixation and 
permeabilization (a, c, and e) 
using mAbs G1/93 against 
ERGIC-53 or 9El0 against 
GM (mAb concentrations: a, 
G1/93 1:50; b, G1/93 1:10; c, 
G1/93 1:2,000; d, G1/93 1:10; e, 
9E10 1:50; f, 9El0 1:10) fol- 
lowed by goat anti-mouse 
FITC. Note that both cells in c 
are transfected, endogenous 
ERGIC-53 is not stained at 
this dilution of mAb G1/93. 
Overexpression of ERGIC-53 
or GM leads to cell surface x- 
pression in some cells whereas 
all of the endogenous ERGIC- 
53 is intracellular in mock- 
transfected cells. The intracel- 
lular patterns of overexpressed 
ERGIC-53 and GM are very 
similar. Bar, 10 txm. 
Neither the Lumenal Nor the Transmembrane Domain 
Is Sufficient for Pre-medial-Golgi Localization 
Within the secretory pathway there is precedence for tar- 
geting mediated by lumenal, transmembrane, and cyto- 
plasmic domains acting alone or in combination (Nilsson 
et al., 1989; Munro, 1991; Sweet and Pelham, 1992; Pon- 
nambalam et al., 1994; Schweizer et al., 1994). To test the 
contribution to targeting of each domain of ERGIC-53 we 
have chosen human CD4, a monomeric, N-glycosylated 
plasma membrane protein as a reporter. To test suffi- 
ciency for correct targeting of the lumenal domain of ER- 
GIC-53 we replaced its transmembrane with that of CD4 
and substituted the cytoplasmic domain with alanines (Fig. 
1., L53T4R2Alo). Targeting sufficiency of the transmem- 
brane domain was tested by replacing the transmembrane 
domain in CD4 by that of ERGIC-53 (Fig. 1, L4T53C4). 
The requirement for the transmembrane domain in ER- 
GIC-53 targeting was addressed by replacing the trans- 
membrane domain with that of CD4 (Fig. 1, L53T4C53). 
COS cells transfected with GM, L53T4C53 and 
L53T4R2AI0 were pulsed for five min with [35S]methionine 
and chased for up to 2 h. The immunoprecipitated mutant 
proteins were digested with endo H and the fraction of re- 
sistant protein determined (Fig. 4 a). GM representing 
overexpressed wild-type ERGIC-53 showed ~10% endo 
H resistance after 1 h of chase (Fig. 4 a). This value was 
identical to that obtained with an ERGIC-53 mutant con- 
taining the N-glycosylation site but no epitope tag (not 
shown). The replacement of the transmembrane domain 
in ERGIC-53 by CD4 (L53T4C53) did not change the ac- 
quisition of endo H resistance, suggesting that it is not re- 
quired for targeting (Fig. 4 a). The inverse construct with 
the ERGIC-53 transmembrane domain in a CD4 back- 
ground IAT53C4 showed similar kinetics of endo H resis- 
tance (Fig. 4b) and comparable localization by immunoflu- 
orescence (not shown) as overexpressed wild type CD4. 
This indicated that the transmembrane domain of ERGIC-53 
was not sufficient for the targeting of ERGIC-53. Substitu- 
tion of both the transmembrane and the cytoplasmic do- 
mains (L53T4R2A10) resulted in ~50% endo H resistance 
after 1 h of chase (Fig. 4 a). The lumenal domain of ER- 
GIC-53 is not sufficient for targeting. 
The Cytoplasmic Domain Is Sufficient 
for Pre-medial-Golgi Localization of a
Reporter Protein 
The above results strongly argued for a role of the cyto- 
plasmic domain in intracellular targeting of ERGIC-53, 
and to analyze this directly two CD4-ERGIC53 constructs 
were generated: IAT4C53, containing only the cytoplasmic 
domain, and IAT53C53 containing the cytoplasmic and the 
transmembrane domain of ERGIC-53 (Fig. 1). Transfected 
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Figure 3. C-myc epitope tag and N-glycosylation site are func- 
tional in modified ERGIC-53 (GM) and do not interfere with oli- 
gomerization. COS cells were transfected with cDNAs encoding 
ERG1C-53 or GM. 44 h after transfection the c lls were labeled 
for five min with [35S]methionine followed by a chase of 15 min, 
and then subjected to immunoprecipitation with the indicated 
mAbs (G1/93 against ERGIC-53, 9El0 against he c-myc epi- 
tope). Where marked the samples were treated with endo H to 
remove N-linked high-mannose glycans and analyzed by SDS- 
PAGE (4-10% slab gel) under educing (DTT+) or nonreducing 
(DTT-) conditions, followed by fluorography. Note that the ex- 
pression levels of overexpressed ERGIC-53 and GM are identi- 
cal and that no detectable endogenous ERGIC-53 is precipitated 
with the c-myc antibody. Numbers at the left margin indicate the 
position of molecular mass tandards inkD. 
COS cells were analyzed by a double immunofluorescence 
procedure which allowed differential staining of the cell 
surface and intracellular membranes (Fig. 5; see Materials 
and Methods). Overexpressed CD4 showed strong surface 
staining under nonpermeabilized and a perinuclear intra- 
cellular staining under permeabilized conditions. The peri- 
nuclear staining most likely represents newly s nthesized 
protein in transit through the Golgi as well as internalized 
CD4 concentrated in endosomes and/or lysosomes. Over- 
expressed CD4 chimera IAT53C53 and L4T4C53, on the 
other hand, showed no surface staining but a strong stain- 
ing indicative of the ER: reticular intracellular staining 
with a nuclear ing (Fig. 5, c-f). It is important to note that 
this staining is distinct from an ERGIC  pattern (see also 
Fig. 8 B). For L4T4C53, a few cells exhibited surface stain- 
ing (insert in Fig. 5, e and f). To confirm these results bio- 
chemically, transfected COS cells were pulse--chased and 
the immunoprecipitates were digested with endo H (data 
Figure 4. ERGIC-53 lumenal and transmembrane domain are 
not sufficient for targeting. (a) Transfected COS cells were 
pulsed for five rain with [35S]methionine and chased for the indi- 
cated times with unlabeled methionine in excess followed by an 
immunoprecipitation with mAb 9El0 against he c-myc epitope. 
The precipitates were digested with endo H and analyzed by 
SDS-PAGE and fluorography. The amount of endo H-resistant 
protein was determined by laser scanner densitometry of fluoro- 
grams. GM (O), L53T4C53 (A), L53T4RzA~0 ([2). The values 
given are means ± SD of triplicate cultures treated in parallel. (b) 
Transfected COS cells were pulsed for 15 min with [35S]methio- 
nine and chased for the indicated times with unlabeled methio- 
nine in excess followed by an immunoprecipitation with mAb 
HP2/6 against CD4. The precipitates were digested with endo H 
and analyzed as described in a. Values are the average of two in- 
dependent experiments. Dark bars, CD4; Light bars, L4T53C4. 
not shown). In contrast to wild-type CD4, the chimeras re- 
mained endo H sensitive after prolonged chase times indi- 
cating a pre-medial-Golgi localization, which is in line 
with the ER-staining observed in Fig. 5. We conclude that 
the cytoplasmic domain of ERGIC-53 is sufficient for pre-  
medial-Golgi targeting. 
The Cytoplasmic Domain Contains Three 
Targeting Features 
To define the targeting signal(s) in the cytoplasmic do- 
main of ERGIC-53, amino acids were serially truncated 
from the COOH terminus. Surprisingly, deletion of up to 
seven amino acids, which eliminated the putative KKXX 
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ER-retr ieval signal, did not substantially change the rate 
of endo H resistance compared to wild type (Fig. 6, lines 2, 
3, 4, and 6). These results suggest that the inner five amino 
acids RSQQE adjacent o the transmembrane domain act 
Figure 5. Double-immunoflu- 
orescence analysis of surface 
and intracellular CD4, 1_AT53C53 
and L4T4C53. Transfected COS 
cells were cooled to 4°C and 
incubated with mAb 6D10 
(IgG1), against CD4, followed 
by IgGl-specific goat anti- 
mouse-FITC to stain protein at 
the cell surface (b, d, and f). 
The cells were then fixed and 
permeabilized followed by an 
incubation with mAb HP2/6.1 
(IgG2a), against CD4, and 
goat anti-mouse IgG2a-spe- 
cific goat anti-mouse-TRITC 
staining the intracellular p o- 
tein (a, c, and e). The DNA's 
used were CD4 (a and b), 
L4T53T53 (c and d) and 
L4T4C53 (e and Y3- Bar corre- 
sponds to 10 ~m in a, b, c, d 
and 22 ~m in e and f. 
as a targeting determinant. To exclude conformational r- 
tifacts due to truncation, which might slow down exit from 
the ER, we restored the authentic tail length by re-adding 
seven alanines to the RSQQE,  and we deleted the KKXX- 
motif in L53T4C53. Both constructs howed equal endo H 
resistance and oligomerization equal to wild type, strongly 
arguing against a runcation artifact (Fig. 6, lines 5 and 7). 
We conclude that the five residues RSQQE adjacent o 
the transmembrane domain constitute a targeting deter- 
minant. 
Figure 6. The cytoplasmic domain of ERGIC-53 contains a 
KKXX-retrieval signal and a second targeting signal adjacent to 
the membrane. Endo H resistance was determined after 5 rain of 
pulse with [35S]methionine followed by 60 min of chase as de- 
scribed in Fig. 4 a. The mutations indicated w re all constructed 
in a GM background, except mutation 5 that was constructed in
L53T4C53 (see Fig. 1). The amino acid sequence of the cytoplas- 
mic domain is given in the single letter code with construct 1rep- 
resenting the wild-type sequence. The values given are means + 
SD of triplicate cultures treated in parallel. Surface appearance 
of the overexpressed proteins was analyzed by indirect immuno- 
fluorescence microscopy staining the cell surface with mAb 9El0 
at 4°C before fixation and permeabilization as described in Fig. 2. 
(a) The cytoplasmic domain of ERGIC-53 contains two targeting 
determinants. (b) The RSQQE determinant is suppressed by aro- 
mates in the -1/-2 position from the COOH terminus. (c) Lysine- 
specificity and position-dependence identify KKFF as a KKXX 
ER-retrieval signal. 
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We next studied the role of the lysines in the cytoplas- 
mic domain of ERGIC-53 (Fig. 6, line 9). A construct with 
two correctly positioned lysines ( -3 / -4  from the COOH 
terminus) but lacking the terminal phenylalanines did not 
acquire endo H resistance and was not transported to the 
cell surface. This construct is significantly different from 
construct 1 (Fig. 6, wt), containing the terminal phenylala- 
nines and from construct 7 (Fig. 6) that contains only the 
RSQQE determinant. It also confirmed that transport of 
ERGIC-53 to the Golgi and the cell surface was not simply 
a question of enforced overexpression but an intrinsic 
property of the cytoplasmic domain. 
Introduction of the two COOH-terminal phenylalanine 
residues in absence of the lysines showed an unexpected 
increase in endo H resistance (Fig. 6, line 8) reflecting com- 
parable rates of transport as shown for L53T4R2AI0 and 
CD4 (Fig. 4). The phenylalanines suppress the targeting 
mediated by the RSQQE determinant. Comparison of a 
mutant with one lysine changed to serine, and the phenyl- 
alanines ubstituted by alanines (KSAA) to mutants with 
phenylalanines or tyrosines present in the -1 / -2  position 
from the COOH terminus (KSFF, KSFY, KSYF, KSYY) 
showed that terminal phenylalanine/tyrosine residues up- 
press the RSQQE determinant (Fig. 6, lines 10-14). 
To assess whether the KKFF sequence is a functional di- 
lysine ER-retrieval signal, we tested two criteria: lysine de- 
pendence and position dependence from the COOH ter- 
minus (Jackson et al., 1990). Both, the lysine dependence 
tested by substitution with arginines (Fig 6, line 15) and 
the position dependence from the COOH terminus tested 
by addition of three alanines to the COOH terminus (Fig. 
6, lines 16 and 17, and compare line 9 to 18) identified the 
KKFF-tetrapeptide as a di-lysine ER-retrieval signal. We 
conclude that the cytoplasmic domain of ERGIC-53 con- 
tains three targeting determinants: a di-lysine ER-retrieval 
signal, a RSQQE determinant adjacent to the membrane 
and two COOH-terminal phenylalanines which influence 
the RSQQE determinant. It is important to note that the 
overall folding of all mutants generated in a GM back- 
ground was controlled by comparing their kinetics of oli- 
Figure 7. The retrieval capacity of the di-lysine signal is reduced 
by the phenylalanines. Endo H resistance was determined as in Fig. 
5. Chase time was 5 h. All constructs were in a GM background 
containing the indicated cytoplasmic domains. Construct 1 co re-
sponds to GM, and construct 2 is identical o construct 9 in Fig. 5. 
The values given are means -+ SD of triplicate cultures treated in 
parallel. 
gomerization to that of ERGIC-53. All mutants hown in 
this paper oligomerize identical to ERGIC-53. 
The COOH-terrainal Phenylalanines Modulate the 
ER-retrieval Signal 
Besides suppressing the inner targeting determinant do 
the COOH-terminal phenylalanines also influence the di- 
lysine signal? Construct 9 in Fig. 6, which had the terminal 
phenylalanines replaced by alanines in the wild-type cyto- 
plasmic domain, was not transported to the medial-Golgi 
after 5 h of chase (Fig. 7, line 2). This result, however, did 
not allow us to conclude that the terminal phenylalanines 
influence the di-lysine motif since in that construct the in- 
ner targeting determinant was not suppressed and could 
have contributed to the intracellular targeting efficiency 
(compare Fig. 7, lines 1 and 2). However, substitution of 
the phenylalanines in RRAAAAAAKKFF by atanines 
enabled us to determine the influence of the phenylala- 
nines on the di-lysine motif. The resulting construct with 
the cytoplasmic amino acid sequence RRAAAAAAK- 
KAA (Fig. 7, line 4) showed no significant ER to medial- 
Golgi transport after 5 h of chase comparable to RSQ- 
QEAAAKKAA (Fig. 7, line 2). Both constructs showed 
expression levels identical to GM and displayed no surface 
staining by immunofluorescence microscopy (data not 
shown). 
We conclude that COOH-terminal phenylalanines re- 
duce the ER-retrieval efficiency mediated by the di-lysine 
motif. 
Correct Targeting ofERGIC-53 Requires 
the Entire Cytoplasmic Domain and the Presence 
of the Lumenal Domain 
As the endo H assay cannot monitor localization within 
the ER-ERGIC-c/s-Golgi cycle we used immunofluores- 
cence microscopy of cells expressing moderate levels of 
protein to distinguish ER from ERGIC and Golgi. High 
expression levels lead to saturation of the recycling path- 
way and result in staining of the cell surface and the endo- 
somal system, a condition that renders a morphological 
analysis impossible (see also Fig. 2). To determine the role 
of the cytoplasmic targeting signals in maintaining ERGIC- 
53 within the ER-ERGIC-cis-Golgi cycle, COS cells were 
transfected with the cDNAs corresponding to the con- 
structs in Fig. 7 with the cytoplasmic domains: RSQ- 
QEAAAKKFF (wild type), RSQQEAAAKKAA, RRA- 
AAAAAKKFF, and RRAAAAAAKKAA. 16 h after 
transfection, corresponding to a threefold increased ex- 
pression of mutant versus endogenous ERGIC-53 (data 
not shown), mutant protein was selectively visualized with 
the mAb against the c-myc epitope. Overexpression of
GM with the cytoplasmic sequence RSQQEAAAKKFF 
lead to the characteristic concentrated perinuclear pattern 
(Fig. 8 A, a) observed for endogenous ERGIC-53 (Fig. 8 
B, b), whereas ubstitution of the terminal phenylalanines 
by alanines (RSQQEAAAKKAA) lead to a typical ER 
pattern with a pronounced staining of the nuclear enve- 
lope and less concentration i  a perinuclear area (Fig. 8 A, 
b). This finding emphasizes the importance of the phenyl- 
alanines in targeting. Proteins terminating  RRAAAA- 
AAKKFF and RRAAAAAAKKAA were localized to 
the nuclear envelope and a reticular network in the cell 
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Figure 8. (A) Immunofluores- 
cence localization of GM (a), 
RSQQEAAAKKAA (b), RRA- 
AAAAAKKFF (c), RR-AAAA- 
AAKKAA (d). (B) Double im- 
munofluorescence localization 
of L4T4C53 (a) with endoge- 
nous ERGIC-53 (b). Trans- 
fected COS cells were subjected 
to indirect immunofluorescence 
16 h after transfection. Staining 
was as described in Fig. 2 with 
mAbs 9E10 (A, a-d) against he 
c-myc-epitope, HP2/6 (B, a) 
against CD4 and G1/93 (B, b) 
against endogenous ERGIC-53. 
Bar, 10 txm. 
periphery (Fig. 8 A, c and d). The finding that neither of 
the two ER-retrieval signals alone was capable of mediat- 
ing wild-type targeting showed the requirement for the 
RSQQE determinant for targeting. Therefore, ERGIC-53 
localization requires all three features in the cytoplasmic 
domain of ERGIC-53: a di-lysine ER-retrieval signal, a 
RSQQE targeting determinant and two COOH-terminal 
phenylalanines modulating both targeting determinants. 
That the different mutants how differences in their distri- 
bution also argues against binding of the mutants to cal- 
nexin or even endogenous ERGIC-53 via their carbohy- 
drate moiety as an explanation for their targeting within 
the ER-ERGIC-cis-Golgi cycle. 
We have shown that virtually the entire cytoplasmic do- 
main is required for targeting of ERGIC-53, but is the cy- 
toplasmic domain of ERGIC-53 also sufficient for correct 
targeting of a reporter protein within the ER-ERGIC-cis- 
Golgi cycle? By double immunofluorescence microscopy 
the pattern of L4T4C53 was compared with endogenous 
ERGIC-53 16 h after transfection. L4T4C53 showed mostly 
an ER pattern with a strong nuclear ring clearly distinct 
from endogenous ERGIC-53 (Fig. 8 B, a and b), while lo- 
calization of a construct containing both the cytoplasmic 
and the lumenal domain of ERGIC-53, L53T4C53, was in- 
distinguishable from GM (not shown). This difference in 
localization may be due to the reduced influence of the 
RSQQE determinant in the CD4-chimera L4T4C53. In- 
deed a CD4-chimera lacking the KKFF-retrieval signal, 
L4T4C53 (K-4stop), acquired 32% endo H resistance after 
1 h of chase (not shown) considerably more than the 12% 
for the corresponding mutation in L53T4C53 (Fig. 6, line 
5). We conclude therefore that the presence of the 
ERGIC-53 lumenal domain is required for a functional 
RSQQE determinant. 
Discussion 
Based on the acquisition of endo H resistance and the lo- 
calization of ERGIC-53 mutants expressed in COS cells 
we have established that both the cytoplasmic and the lu- 
menal domain of the protein are required for correct ar- 
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geting of ERGIC-53. We have further shown under high 
and confirmed under low expression conditions that the 
cytoplasmic domain contains three targeting determinants: 
a functional di-lysine ER-retrieval signal, a determinant 
RSQQE adjacent o the membrane and two COOH-ter- 
minal phenylalanines that modulate both. 
Acquisition of Endo H Resistance Reflects Loss of 
Intracellular Retention of ERGIC-53 
Since endogenous ERGIC-53 has not been found in com- 
partments beyond the cis-Golgi we have exploited the ac- 
quisition of endo H resistance of the glycosylated ERGIC- 
53 variant GM as a principal measure for the rate of loss 
from the ER-ERGIC-cis-Golgi system. This assay reveals 
subtle changes in the overall retention of GM mutants in 
the pre-mediaI-Golgi recycling pathway, provided the ex- 
pression levels of the different constructs are comparable, 
a condition that was met in our experiments. However, the 
assay does not discriminate between recycling of overex- 
pressed ERGIC-53 (GM) from post-medial-Golgi com- 
partments and transport to the cell surface. Three findings 
argue against a major contribution of recycling from late 
Golgi sites. First, ER-localized GM in highly overexpress- 
ing COS cells failed to costain with FITC-ricin, a lectin 
recognizing -(1,4)-linked galactose added in the trans- 
Golgi (not shown). Jackson et al. (1993) reported ER 
staining by Helix pomatia lectin (recognizing terminal 
GalNAc) and peanut lectin (recognizing terminal Gal- 
(1,3)-GalNAc) in cells overexpressing an O-glycosylated 
CD8/E19 chimeric protein possessing a di-lysine ER- 
retrieval signal. While this result is evidence for recycling 
of a di-lysine protein via the Golgi apparatus it does not 
necessarily indicate recycling from the trans-Golgi. Helix 
pomatia lectin recognizes terminal GalNAc added both in 
the cis-Golgi (Roth et al., 1994) and the trans-Golgi (Roth, 
1984), and peanut lectin binds glycans in the medial-Golgi 
(Roth, 1987). Second, we found a strict correlation be- 
tween the acquisition of endo H resistance and mislocal- 
ization to the cell surface of the different mutant proteins. 
Third, we have shown that ERGIC-53 contains a func- 
tional di-lysine ER-retrieval signal, and a recycling path- 
way from the ERGIC and the cis-Golgi s consistent with 
the major localization of coatomer, the putative receptor 
for di-lysine signals (Oprins et al., 1993; Cosson and Le- 
tourneur, 1994; Letourneur et al., 1994). Collectively, our 
data argue against ERGIC-53 recycling from the trans- 
Golgi to biosynthetically earlier compartments. We con- 
clude therefore that the acquisition of endo H resistance 
reflects loss of intracellular retention of ERGIC-53. 
An alternative approach to characterize loss of intracel- 
lular targeting would be to record cell surface appearance 
of overexpressed ERGIC-53 mutants. However, transient 
overexpression of wild-type ERGIC-53 leads to cell sur- 
face mislocalization in 5-10% of the transfected cells 
(Kappeler et al., 1994). Surface-mislocalized ERGIC-53 
protein efficiently internalizes and internalization is strongly 
affected by mutations in the cytoplasmic domain (Kap- 
peler et al., 1994; Itin et al., 1995). As a consequence the 
amount of ERGIC-53 at the cell surface is a combined re- 
sult of loss of intracellular targeting and internalization 
both of which can be differentially affected by mutations. 
These considerations invalidate surface appearance of 
ERGIC-53 mutants as a measure for loss of intracellular 
targeting. 
Targeting of ERGIC-53 
We have analyzed the targeting of ERGIC-53 in two steps. 
First, we identified the signals involved in pre-medial- 
Golgi localization by a biochemical approach under high 
expression conditions, and second, we tested whether the 
signals defined by this assay were required for the correct 
localization of ERGIC-53 within the ER-ERGIC-cis-Golgi 
system. For this purpose we analyzed by immunofluores- 
cence microscopy the distribution of mutant ERGIC-53 
proteins expressed at moderate xpression levels, which is 
three times on average the level of endogenous ERGIC- 
53. This second analysis confirmed that the signals identi- 
fled under high expression conditions are true targeting 
determinants and not simply an artefactual result due to 
excessive overexpression. 
Our data indicate that pre-medial-Golgi targeting of 
ERGIC-53 depends to a large extent on the retrieval ca- 
pacity of the di-lysine signal in its cytoplasmic domain, 
even though an RSQQE determinant and two COOH-ter- 
minal phenylalanines are required for correct localization 
within the ER-ERGIC-cis-Golgi recycling pathway. How- 
ever, the cytoplasmic domain alone is not sufficient o tar- 
get a monomeric reporter protein, L4T4C53, identically to
endogenous ERGIC-53. A comparison of the acquisition 
of endo H resistance between monomeric L4T4C53 
K(-4)stop and oligomeric L53T4C53 (K-4)stop, both lack- 
ing the KKFF ER-retrieval signal, is most consistent with 
the idea that the RSQQE determinant is reduced or non- 
functional in the monomeric background. But how could 
oligomerization i fluence the RSQQE determinant? Two 
of the four cysteine residues, which could potentially link 
ERGIC-53 oligomers by disulfide bridges, are located 
within a 15-amino acid distance from the transmembrane 
domain. Provided these cysteines covalently link the 
ERGIC-53 oligomers in the immediate vicinity of the 
membrane, this could actually lead to a close apposition of 
the RSQQE determinants on the cytoplasmic side of the 
membrane. It is conceivable that such an apposition is re- 
quired for the RSQQE determinant to be functional, a sit- 
uation not mimicked in the monomeric reporter protein. 
It is not clear what kind of interaction ismediated by the 
RSQQE determinant. It could act as an imperfect reten- 
tion signal slowing transit hrough the ERGIC and thereby 
contribute to the steady-state distribution of the protein. 
The fact that RSQQE is also functional when the trans- 
membrane domain in GM is exchanged with that of CD4 
in L53T4C53 indicates that this signal is not part of a trans- 
membrane retention determinant, and hence the retention 
mechanism appears to be unrelated to that of Golgi pro- 
teins (Nilsson and Warren, 1994). 
A different explanation for the involvement of the lu- 
menal domain in the targeting of ERGIC-53 could be a lu- 
menal interaction with other proteins as a consequence of
ERGIC-53's function. The finding of Arar et al. (1995) 
that ERGIC-53 is identical to an intracellular mannose- 
specific lectin points to the possibility that ERGIC-53 may 
facilitate ER to Golgi transport of newly synthesized gly- 
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coproteins. Alternatively, ERGIC-53 may act as a chaper- 
one downstream of calnexin (Hammond et al., 1994; Ham- 
mond and Helenius, 1994; Helenius, 1994) adding an 
additional level of quality control in the maturation pro- 
cess of glycoproteins. Either of these functions would in- 
volve the lumenal domain. Ligand binding may exert an 
allosteric effect on the cytoplasmic domain modulating the 
interaction with coatomer and thereby regulate the cycling 
of ERGIC-53. If so, a contribution of the lectin domain to 
sorting would only be apparent at moderate expression 
levels when enough ligand is available. The strong ER 
staining of highly overexpressed ERGIC-53 and GM as 
compared to the concentrated pattern seen under moder- 
ate expression would be consistent with this notion. 
Role of the Phenylalanines 
We observed that the COOH-terminal phenylalanines re- 
duce the ER-retrieval capacity of the di-lysine signal and 
substitution of the phenylalanines in ERGIC-53 by ala- 
nines resulted in ER localization. Furthermore, consistent 
with a pre-Golgi localization, this construct when ex- 
pressed in LEC-1 cells, which lack the medial-Golgi en- 
zyme N-acetylglucosaminyl transferase, did not become 
endoglycosidase D sensitive and hence did not reach the 
cis-Golgi site where mannosidase I trimming occurs (F. 
Kappeler, C. Itin, and H.-P. Hauri, unpublished observa- 
tions). This is in contrast to endogenous ERGIC-53, a mi- 
nor fraction of which is localized to the cis-Golgi (Schwei- 
zer et al., 1988; Foguet, M., and H.-P. Hauri, unpublished 
observation). These observations uggest that in absence 
of the phenylalanines ERGIC-53 protein is efficiently re- 
trieved before reaching the cis-Golgi, while in the pres- 
ence of the phenylalanines transport to the cis-Golgi 
can occur. Subcellular fractionation experiments indeed 
showed that endogenous ERGIC-53 is retrieved to the ER 
from two sites. A major fraction directly recycles from the 
ERGIC without prior passage through t e cis-Golgi, while 
a minor fraction has access to the cis-Golgi (Foguet, M., 
and H.-P. Hauri, unpublished observation). 
Based on our finding that the phenylalanines reduce the 
pre-Golgi targeting efficiency of the di-lysine ER-retrieval 
signals, we propose that they reduce the efficiency of rec- 
ognition of the di-lysine signal by coatomer in the ERGIC, 
and thereby allow a fraction of ERGIC-53 to be trans- 
ported to the cis-Golgi. 
Mechanism of ERGIC-53 Targeting 
In summary our data suggest a model for ERGIC-53 tar- 
geting that is based on an active di-lysine ER-retrieval sig- 
nal that acts together with the COOH-terminal phenylala- 
nines, the RSQQE determinant and the lumenal domain 
to allow a post-ER localization. Localization of ERGIC-53 
in the ER/ERGIC/cis-Golgi system is a result of retrieval 
and retention. In line with the most recent suggestion that 
COP's may not be involved in anterograde transport but 
in selective retrieval of di-lysine-signal-bearing proteins 
(Letourneur et al., 1994; Pelham, 1994) it is conceivable 
that KKFF is a retrieval signal whose binding to COPs is 
weak due to the presence of two COOH-terminal phenyl- 
alanines. Reduced COP binding may result in less efficient 
retrieval that in turn would shift the overall distribution 
from ER to ERGIC. In contrast, RSQQE together with 
the lumenal domain may function as a retention signal 
leading to the known concentration of protein ERGIC-53 
in the ERGIC. Subcellular fractionation and COP binding 
studies will be required to test the role of the individual 
targeting determinants. 
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